Clinical Trials Browser

Interventional × darolutamide × Tumor-Agnostic × Clear all

NCT04464226 2025-11-06

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

Phase 3 Recruiting

Neoplasms

NCT03314324 2025-04-17

ODENZA

Phase 2 Completed

Neoplasms